相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Necroptosis is dispensable for the development of inflammation-associated or sporadic colon cancer in mice
Silvia Alvarez-Diaz et al.
CELL DEATH AND DIFFERENTIATION (2021)
RIPK3 signaling and its role in the pathogenesis of cancers
Shanhui Liu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
OTULIN maintains skin homeostasis by controlling keratinocyte death and stem cell identity
Esther Hoste et al.
NATURE COMMUNICATIONS (2021)
MLKL in cancer: more than a necroptosis regulator
Sofie Martens et al.
CELL DEATH AND DIFFERENTIATION (2021)
MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSF
Xin Wang et al.
CELL DEATH AND DIFFERENTIATION (2021)
Differences in tumor initiation and progression of melanoma in the BrafCA;Tyr-CreERT2;Ptenf/f model between male and female mice
Yougang Zhai et al.
PIGMENT CELL & MELANOMA RESEARCH (2020)
Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5
Yohei Ando et al.
PLOS ONE (2020)
An alternative pathway for cellular protection in BRAF inhibitor resistance in aggressive melanoma type skin cancer
Xiang-Lin Mei et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2020)
Melanoma immunotherapy: strategies to overcome pharmacological resistance
Claudia Trojaniello et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2020)
The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype
Niels Vandamme et al.
CANCER RESEARCH (2020)
Intrinsic Balance between ZEB Family Members Is Important for Melanocyte Homeostasis and Melanoma Progression
Kenneth Bruneel et al.
CANCERS (2020)
Lymph protects metastasizing melanoma cells from ferroptosis
Jessalyn M. Ubellacker et al.
NATURE (2020)
TAK1 suppresses RIPK1-dependent cell death and is associated with disease progression in melanoma
Biswajit Podder et al.
CELL DEATH AND DIFFERENTIATION (2019)
Upregulated necroptosis-pathway-associated genes are unfavorable prognostic markers in low-grade glioma and glioblastoma multiforme
Yuanli Doug et al.
TRANSLATIONAL CANCER RESEARCH (2019)
Depletion of MLKL inhibits invasion of radioresistant nasopharyngeal carcinoma cells by suppressing epithelial-mesenchymal transition
Yuanli Dong et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Necroptosis of tumor cells leads to tumor necrosis and promotes tumor metastasis
Delong Jiao et al.
CELL RESEARCH (2018)
Low Necroptosis Process Predicts Poor Treatment Outcome of Human Papillomavirus Positive Cervical Cancers by Decreasing Tumor-Associated Macrophages M1 Polarization
Lin Li et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2018)
Cell death-based treatments of melanoma: conventional treatments and new therapeutic strategies
Gianfranco Mattia et al.
CELL DEATH & DISEASE (2018)
Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosis
Emma J. Petrie et al.
NATURE COMMUNICATIONS (2018)
Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes
Lien Van Hoecke et al.
NATURE COMMUNICATIONS (2018)
BRAF and AXL oncogenes drive RIPK3 expression loss in cancer
Ayaz Najafov et al.
PLOS BIOLOGY (2018)
Molecular Pathways: The Necrosome-A Target for Cancer Therapy
Lena Seifert et al.
CLINICAL CANCER RESEARCH (2017)
Association of Mixed Lineage Kinase Domain-Like Protein Expression With Prognosis in Patients With Colon Cancer
Xian Li et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2017)
The mitogen-activated protein kinase pathway in melanoma part I - Activation and primary resistance mechanisms to BRAF inhibition
Teresa Amaral et al.
EUROPEAN JOURNAL OF CANCER (2017)
Pseudokinases: update on their functions and evaluation as new drug targets
Dominic P. Byrne et al.
FUTURE MEDICINAL CHEMISTRY (2017)
Relevance of necroptosis in cancer
Najoua Lalaoui et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
DNA methylation-mediated caspase-8 downregulation is associated with anti-apoptotic activity and human malignant glioma grade
Yueqiu Teng et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
Pro-necrotic molecules impact local immunosurveillance in human breast cancer
Gautier Stoll et al.
ONCOIMMUNOLOGY (2017)
Downregulation of Caspase 8 in a group of Iranian breast cancer patients - A pilot study
Masoumeh Aghababazadeh et al.
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE (2017)
RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating Cells
Ulrike Hoeckendorf et al.
CANCER CELL (2016)
Activation of cell-surface proteases promotes necroptosis, inflammation and cell migration
Zhenyu Cai et al.
CELL RESEARCH (2016)
The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression
Lena Seifert et al.
NATURE (2016)
Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis
Boris Strilic et al.
NATURE (2016)
Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric caner
Zhai Ertao et al.
TUMOR BIOLOGY (2016)
Key roles of necroptotic factors in promoting tumor growth
Xinjian Liu et al.
ONCOTARGET (2016)
Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity
Tania Love Aaes et al.
CELL REPORTS (2016)
Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy
Heng Yang et al.
ONCOIMMUNOLOGY (2016)
Chromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomas
Crystal S. Seldon et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
RIPK1 regulates survival of human melanoma cells upon endoplasmic reticulum stress through autophagy
Qi Luan et al.
AUTOPHAGY (2015)
The serine threonine kinase RIP3: lost and found
Michael J. Morgan et al.
BMB REPORTS (2015)
RIP1 Kinase Is an Oncogenic Driver in Melanoma
X. Y. Liu et al.
CANCER RESEARCH (2015)
Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics
Gi-Bang Koo et al.
CELL RESEARCH (2015)
Passenger Mutations Confound Interpretation of All Genetically Modified Congenic Mice
Tom Vanden Berghe et al.
IMMUNITY (2015)
Necroptosis and its role in inflammation
Manolis Pasparakis et al.
NATURE (2015)
Absence of RIPK3 predicts necroptosis resistance in malignant melanoma
P. Geserick et al.
CELL DEATH & DISEASE (2015)
Insights into the evolution of divergent nucleotide-binding mechanisms among pseudokinases revealed by crystal structures of human and mouse MLKL
James M. Murphy et al.
BIOCHEMICAL JOURNAL (2014)
RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65/RelA cleavage
A-L Nugues et al.
CELL DEATH & DISEASE (2014)
Melanoma cells revive an embryonic transcriptional network to dictate phenotypic heterogeneity
Niels Vandamme et al.
FRONTIERS IN ONCOLOGY (2014)
Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma
Lauren E. Colbert et al.
CANCER (2013)
A Switch in the Expression of Embryonic EMT-Inducers Drives the Development of Malignant Melanoma
Julie Caramel et al.
CANCER CELL (2013)
The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism
James M. Murphy et al.
IMMUNITY (2013)
MDM4 is a key therapeutic target in cutaneous melanoma
Agnieszka Gembarska et al.
NATURE MEDICINE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Phenotypic Heterogeneity among Tumorigenic Melanoma Cells from Patients that Is Reversible and Not Hierarchically Organized
Elsa Quintana et al.
CANCER CELL (2010)
Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α
Sudan He et al.
CELL (2009)
BrafV600E cooperates with Pten loss to induce metastatic melanoma
David Dankort et al.
NATURE GENETICS (2009)
Melanoma biology and new targeted therapy
Vanessa Gray-Schopfer et al.
NATURE (2007)
Microarray analysis of promoter methylation in lung cancers
M Fukasawa et al.
JOURNAL OF HUMAN GENETICS (2006)
Kinase RIP3 is dispensable for normal NF-KBs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and toll-like receptors 2 and 4
K Newton et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)